Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 2.62% | $3.63M | $637.68B | 35.41% | 74 Outperform | |
| Chevron | 1.96% | $2.72M | $367.67B | 15.98% | 71 Outperform | |
| Johnson & Johnson | 1.85% | $2.57M | $574.95B | 52.85% | 78 Outperform | |
| HSBC Holdings | 1.41% | $1.95M | £226.51B | 49.15% | 80 Outperform | |
| Philip Morris | 1.33% | $1.84M | $283.05B | 22.87% | 61 Neutral | |
| AbbVie | 1.32% | $1.82M | $394.59B | 16.38% | 66 Neutral | |
| Merck & Company | 1.27% | $1.76M | $292.01B | 35.95% | 80 Outperform | |
| Altria Group | 1.25% | $1.74M | $108.11B | 19.59% | 64 Neutral | |
| PepsiCo | 1.16% | $1.61M | $227.51B | 14.30% | 78 Outperform | |
| Intesa Sanpaolo SpA | 1.14% | $1.58M | €105.08B | 36.77% | 76 Outperform |